Nuo Therapeutics, Inc.
SEC CIK 1091596 · gtf · last insider filing 2026-06-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Jorden David Emerson | Director · CEO/CFO | filed 2008 - 2026 |
| Pittman Scott M. | Director | filed 2016 - 2026 |
| Winzer C Eric | Director | filed 2009 - 2025 |
| Mintz Paul | Director | filed 2017 - 2025 |
| Atinsky Lawrence | Director | filed 2016 - 2019 |
| DEL Guercio Joseph | Director | filed 2012 - 2017 |
| Hohnke Lyle A | Director | filed 2012 - 2015 |
| Mcloughlin Mark T | Director | filed 2006 - 2015 |
| Keith Stephen | Director | filed 2008 - 2015 |
| Rosendale Martin P | Director · Chief Operating Officer | filed 2008 - 2014 |
| Kent Richard S | Director | filed 2012 - 2014 |
| Benson James | Director | filed 2006 - 2013 |
| Mendelsohn Craig B | Director | filed 2009 - 2012 |
| Crews David | Director | filed 2006 - 2009 |
| Deva Arun Kumar | Director | filed 2006 - 2008 |
| Mohan Kshitij | Director · Chief Executive Officer | filed 2006 - 2008 |
| Drohan David F | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Clausen Peter | Chief Scientific Officer | filed 2014 - 2025 |
| Tozer Dean | Chief Commercial Officer | filed 2014 - 2014 |
| Shallcross Steven A | SEE REMARKS | filed 2013 - 2014 |
| Field Edward L. | Chief Operating Officer | filed 2012 - 2014 |
| Maslan Andrew Scott | Officer | filed 2006 - 2012 |
| Vanek Patrick Paul | VP of Operations | filed 2010 - 2012 |
| Fylling Carelyn P | VP of Professional Sevices | filed 2006 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.